Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing cause of morbidity with limited treatment options. Thus, accurate in vitro systems to test new therapies are indispensable. While recently, human liver organoid models have emerged to assess steatotic liver disease, a systematic evaluation of their translational potential is still missing. Here, we evaluated human liver organoid models of MASLD, comparatively testing disease induction in three conditions: oleic acid, palmitic acid, and TGF‐β1. Through single‐cell analyses, we find that all three models induce inflammatory signatures, but only TGF‐β1 promotes collagen production, fibrosis, and hepatic stellate cell expansion. In striking contrast, oleic acid ameliorates fibrotic signatures and reduces the hepatic stellate cell population. Linking data from each model to gene expression signatures associated with MASLD disease progression further demonstrates that palmitic acid and TGF‐β1 more robustly model inflammation and fibrosis. Our findings highlight the importance of stratifying MASLD organoid models by signatures of clinical disease progression, provide a single‐cell reference to benchmark future organoid injury models, and allow us to study evolving steatohepatitis, fibrosis, and HSC susceptibility to injury in a dynamic, multi‐lineage human in vitro system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MultiQC: summarize analysis results for multiple tools and samples in a single report
Ewels, P., Magnusson, M., Lundin, S., & Käller, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw354 · Cited by 10,143
seaborn: statistical data visualization
Waskom, M. (2021) · Journal of Open Source Software · doi:10.21105/joss.03021 · Cited by 7,310 · cited 1×
“Clustered heat maps with euclidean distance dendrograms were created using seaborn (Waskom, 2021) based on either the delta of interactions or the total interaction count.”
MethodFrom Louvain to Leiden: guaranteeing well-connected communities
Traag, V. A., Waltman, L., & van Eck, N. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-41695-z · Cited by 5,635 · cited 1×
“Clusters were identified with the Leiden algorithm (Traag et al , 2019) at resolution 0.1.”
MethodInfluentialEstruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616 · cited 2×
“To resolve transcripts specific to each terminal state, we projected the imputed expression of genes enriched in the above analyses or related to hepatocyte precursor states on the force directed layout for each lineage (Fig 6H).”
The Gene Ontology resource: enriching a GOld mine
The Gene Ontology Consortium, Carbon, S., Douglass, E., Good, B. M., Unni, D. R., Harris, N. L., Mungall, C. J., Basu, S., Chisholm, R. L., Dodson, R. J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1113 · Cited by 3,555
Efremova, M., Vento-Tormo, M., Teichmann, S. A., & Vento-Tormo, R. (2020) · Nature Protocols · doi:10.1038/s41596-020-0292-x · Cited by 3,449
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Scrublet: computational identification of cell doublets in single-cell transcriptomic data
Wolock, S. L., Lopez, R., & Klein, A. M. (2018) · doi:10.1101/357368 · Cited by 2,758 · cited 1×
“Doublet scores were calculated with Scrublet (version 0.2.3) (Wolock et al , 2019) with default settings on the cellranger filtered count matrices.”
MethodInfluentialDisease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196 · cited 1×
“The iPSC4 line was generated through approaches as previously described (Park et al , 2008; Muratore et al , 2014) using cDNAs for Oct4, Sox2, Klf4, and Myc delivered with Sendai Virus.”
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024 · cited 3×
“This leads to the secretion of cytokines such as tumor necrosis factor (TNF) (Anstee et al , 2019; Kisseleva & Brenner, 2021), activating resident liver macrophages (Kupffer cells) (Sunami et al , 2012).”
BackgroundResultMechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · cited 6×
“Canonical transcriptional changes in steatohepatitis include the activation of TNFA (Loomba et al , 2021), while induction of the alpha-1 subunit of type 1 collagen ( COL1A1 ) is characteristic of fibrosis (Ramachandran et al , 2019).”
BackgroundInfluentialRecovering Gene Interactions from Single-Cell Data Using Data Diffusion
van Dijk, D., Sharma, R., Nainys, J., Yim, K., Kathail, P., Carr, A. J., Burdziak, C., Moon, K. R., Chaffer, C. L., Pattabiraman, D., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.061 · Cited by 1,829
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · cited 3×
“Hallmarks of fibrosis include the up-regulation of transcripts COL1A1 , COL3A1 , TIMP1 , TNFS members, and the receptor-ligand-pair PDGFB / PDGFR (Tsuchida & Friedman, 2017; Ramachandran et al , 2019).”
BackgroundSepanlou, S. G., Safiri, S., Bisignano, C., Ikuta, K. S., Merat, S., Saberifiroozi, M., Poustchi, H., Tsoi, D., Colombara, D. V., Abdoli, A., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30349-8 · Cited by 1,714 · cited 2×
“It is among the most common causes of chronic liver disease (Sepanlou et al , 2020) and the most rapidly increasing indication for liver transplantation in the United States (Younossi et al , 2021).”
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
MacParland, S. A., Liu, J. C., Ma, X.-Z., Innes, B. T., Bartczak, A. M., Gage, B. K., Manuel, J., Khuu, N., Echeverri, J., Linares, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06318-7 · Cited by 1,552 · cited 3×
“…, and POU5F1 by day 16 of differentiation and induction of the human liver genes ASGR1 and HNF4A (hepatocyte markers, Aizarani et al , 2019), KRT19 / CK19 and SOX9 (cholangiocyte markers, MacParland et al , 2018) as well as VIM and DES (HSC markers, Payen et al , 2021) in day 21 HLOs (Fig 1B).”
BackgroundMethodFrom NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392 · cited 13×
“Metabolic dysfunction-associated steatotic liver disease (MASLD, also known as non-alcoholic fatty liver disease or NAFLD) (Rinella et al , 2023) is tightly linked to obesity and metabolic syndrome (Anstee et al , 2019).”
BackgroundInfluentialA human liver cell atlas reveals heterogeneity and epithelial progenitors
Aizarani, N., Saviano, A., Sagar, Mailly, L., Durand, S., Herman, J. S., Pessaux, P., Baumert, T. F., & Grün, D. (2019) · Nature · doi:10.1038/s41586-019-1373-2 · Cited by 1,147 · cited 1×
“…genes SOX2 , NANOG , and POU5F1 by day 16 of differentiation and induction of the human liver genes ASGR1 and HNF4A (hepatocyte markers, Aizarani et al , 2019), KRT19 / CK19 and SOX9 (cholangiocyte markers, MacParland et al , 2018) as well as VIM and DES (HSC markers, Payen et al ,…”
BackgroundNeuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077 · cited 1×
“A key prerequisite for MASLD-associated chronic liver injury is the continued exposure to excess fatty acids (Nehra et al , 2001; Donnelly et al , 2005; Neuschwander-Tetri, 2010).”
BackgroundDinu, M., Pagliai, G., Casini, A., & Sofi, F. (2018) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.58 · Cited by 1,016 · cited 1×
“Olive oil is an integral component of the Mediterranean diet (MD) (Dinu et al , 2018), and growing evidence over the past decades has demonstrated health benefits from the MD, attributed to its high olive oil content (Dinu et al , 2018).”
BackgroundA multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2023.101133 · Cited by 844
Palantir characterizes cell fate continuities in human hematopoiesis
Setty, M., Kiseliovas, V., Levine, J., Gayoso, A., Mazutis, L., & Pe’er, D. (2018) · doi:10.1101/385328 · Cited by 836
Characterization of cell fate probabilities in single-cell data with Palantir
Setty, M., Kiseliovas, V., Levine, J., Gayoso, A., Mazutis, L., & Pe’er, D. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0068-4 · Cited by 833 · cited 3×
“We investigated the projection of our steatosis (OA), steatohepatitis (PA), and fibrosis model (TGF-β 1) on a force-directed layout in conjunction with Palantir (Setty et al , 2019) trajectory inference analysis to dissect this process.”
MethodTGF-β1 Signaling and Tissue Fibrosis
Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800
Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation.
Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., & Massague, J. (1990) · Cell · doi:10.1016/0092-8674(90)90251-9 · Cited by 797
Hepatic stellate cells in liver development, regeneration, and cancer
Yin, C., Evason, K. J., Asahina, K., & Stainier, D. Y. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66369 · Cited by 719 · cited 2×
“While HSC-and cholangiocyte-like cells decrease in OS conditions, they remain more frequent than observed in the liver, where both cell types comprise about 5% of cells (Yin et al , 2013; Banales et al , 2019).”
Sharma, A., Seow, J. J. W., Dutertre, C.-A., Pai, R., Blériot, C., Mishra, A., Wong, R. M. M., Singh, G. S. N., Sudhagar, S., Khalilnezhad, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.040 · Cited by 677
Delgado-Lista, J., Alcala-Diaz, J. F., Torres-Peña, J. D., Quintana-Navarro, G. M., Fuentes, F., Garcia-Rios, A., Ortiz-Morales, A. M., Gonzalez-Requero, A. I., Perez-Caballero, A. I., Yubero-Serrano, E. M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00122-2 · Cited by 642
A comparison of automatic cell identification methods for single-cell RNA sequencing data
Abdelaal, T., Michielsen, L., Cats, D., Hoogduin, D., Mei, H., Reinders, M. J. T., & Mahfouz, A. (2019) · Genome Biology · doi:10.1186/s13059-019-1795-z · Cited by 628
Immune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573
Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids
Ouchi, R., Togo, S., Kimura, M., Shinozawa, T., Koido, M., Koike, H., Thompson, W., Karns, R. A., Mayhew, C. N., McGrath, P. S., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.007 · Cited by 537
Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration
Raven, A., Lu, W.-Y., Man, T. Y., Ferreira-Gonzalez, S., O’Duibhir, E., Dwyer, B. J., Thomson, J. P., Meehan, R. R., Bogorad, R., Koteliansky, V., et al. (2017) · Nature · doi:10.1038/nature23015 · Cited by 533
Banales, J. M., Huebert, R. C., Karlsen, T., Strazzabosco, M., LaRusso, N. F., & Gores, G. J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0125-y · Cited by 517 · cited 1×
“While HSC-and cholangiocyte-like cells decrease in OS conditions, they remain more frequent than observed in the liver, where both cell types comprise about 5% of cells (Yin et al , 2013; Banales et al , 2019).”
BackgroundDuctular reaction in liver diseases: pathological mechanisms and translational significances
Sato, K., Marzioni, M., Meng, F., Francis, H., Glaser, S., & Alpini, G. (2019) · Hepatology · doi:10.1002/hep.30150 · Cited by 423 · cited 2×
“…liver injury is also associated with the expansion of cells with ductular characteristics, which can originate from cholangiocytes, hepatic progenitors, and hepatocytes to replace injured hepatocytes (Espa ~ nol-Su ~ ner et al , 2012; Raven et al , 2017; Deng et al , 2018; Sato et al , 2019).”
BackgroundResultMuratore, C. R., Rice, H. C., Srikanth, P., Callahan, D. G., Shin, T., Benjamin, L. N. P., Walsh, D. M., Selkoe, D. J., & Young-Pearse, T. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu064 · Cited by 379 · cited 1×
“The iPSC4 line was generated through approaches as previously described (Park et al , 2008; Muratore et al , 2014) using cDNAs for Oct4, Sox2, Klf4, and Myc delivered with Sendai Virus.”
MethodHigh-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell–Derived Organoids
Shinozawa, T., Kimura, M., Cai, Y., Saiki, N., Yoneyama, Y., Ouchi, R., Koike, H., Maezawa, M., Zhang, R.-R., Dunn, A., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.10.002 · Cited by 378 · cited 1×
“Recently, the generation of multi-lineage hepatic organoids from human pluripotent stem cells (hPSCs) has emerged (Ouchi et al , 2019; Wu et al , 2019; Sekine et al , 2020; Guan et al , 2021; Shinozawa et al , 2021).”
BackgroundLiver Progenitor Cells Yield Functional Hepatocytes in Response to Chronic Liver Injury in Mice
Español–Suñer, R., Carpentier, R., Van Hul, N., Legry, V., Achouri, Y., Cordi, S., Jacquemin, P., Lemaigre, F., & Leclercq, I. A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.024 · Cited by 356
Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids
Marsee, A., Roos, F. J. M., Verstegen, M. M. A., Marsee, A., Roos, F., Verstegen, M., Clevers, H., Vallier, L., Takebe, T., Huch, M., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.005 · Cited by 310 · cited 1×
“These systems contain cells of at least endodermal and mesodermal identity (e.g., hepatocyte-, cholangiocyte-, and HSC-like cells) and are also referred to as multi-tissue organoids (Marsee et al , 2021).”
BackgroundMulti-lineage human iPSC-derived platforms for disease modeling and drug discovery
Sharma, A., Sances, S., Workman, M. J., & Svendsen, C. N. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.02.011 · Cited by 296 · cited 1×
“Recent multi-lineage in vitro organoid systems, such as human liver organoids (HLOs), hold the promise to bridge the gap between cell culture and clinical observations (Sharma et al , 2020).”
BackgroundChronic Liver Injury Induces Conversion of Biliary Epithelial Cells into Hepatocytes
Deng, X., Zhang, X., Li, W., Feng, R.-X., Li, L., Yi, G.-R., Zhang, X.-N., Yin, C., Yu, H.-Y., Zhang, J.-P., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.022 · Cited by 289 · cited 4×
“Evaluation of marker gene profiles revealed that DC-like cells were positive for KRT19 and HNF4A as previously reported for a bi-potent cell type induced under conditions of chronic liver injury (Deng et al , 2018; Pu et al , 2023).”
BackgroundResultInfluentialHuman Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease
Ramli, M. N. B., Lim, Y. S., Koe, C. T., Demircioglu, D., Tng, W., Gonzales, K. A. U., Tan, C. P., Szczerbinska, I., Liang, H., Soe, E. L., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.010 · Cited by 278
Haigh, L., Kirk, C., El Gendy, K., Gallacher, J., Errington, L., Mathers, J. C., & Anstee, Q. M. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.06.037 · Cited by 209 · cited 1×
“…on cardiovascular disease are well established (Estruch et al , 2018; Delgado-Lista et al , 2022), and a recent meta-analysis of randomized controlled trials highlights the positive effects of the MD in MASLD, with the observation of reduced ALT levels and liver stiffness (Haigh et al , 2022).”
BackgroundLodyga, M., Cambridge, E., Karvonen, H. M., Pakshir, P., Wu, B., Boo, S., Kiebalo, M., Kaarteenaho, R., Glogauer, M., Kapoor, M., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aao3469 · Cited by 181 · cited 1×
“Kupffer cells and recruited immune cells (Zigmond et al , 2014) are a source of transforming growth factor beta (TGF-β ) (Lodyga et al , 2019), which activates hepatic stellate cells (HSCs), and promotes their transdifferentiation towards myofibro-blasts (Tsuchida & Friedman, 2017).”
BackgroundWang, S., Li, K., Pickholz, E., Dobie, R., Matchett, K. P., Henderson, N. C., Carrico, C., Driver, I., Borch Jensen, M., Chen, L., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add3949 · Cited by 176 · cited 1×
“SMC-like cells with PA and TGF-β 1 treatment induced autocrine interactions through SPP1 and CD44 , consistent with the behavior of activated HSCs in mouse and human MASH livers (Wang et al , 2023).”
the Human Cell Atlas ‘Biological Network’ Organoids, Bock, C., Boutros, M., Camp, J. G., Clarke, L., Clevers, H., Knoblich, J. A., Liberali, P., Regev, A., Rios, A. C., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00762-x · Cited by 171 · cited 1×
“Single-cell RNA sequencing (scRNA-seq) has emerged as a key tool to identify disease signatures in human organoids at high resolution (Bock et al , 2021).”
MethodSingle-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity
Payen, V. L., Lavergne, A., Alevra Sarika, N., Colonval, M., Karim, L., Deckers, M., Najimi, M., Coppieters, W., Charloteaux, B., Sokal, E. M., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100278 · Cited by 160 · cited 1×
“…, and POU5F1 by day 16 of differentiation and induction of the human liver genes ASGR1 and HNF4A (hepatocyte markers, Aizarani et al , 2019), KRT19 / CK19 and SOX9 (cholangiocyte markers, MacParland et al , 2018) as well as VIM and DES (HSC markers, Payen et al , 2021) in day 21 HLOs (Fig 1B).”
BackgroundA human multi-lineage hepatic organoid model for liver fibrosis
Guan, Y., Enejder, A., Wang, M., Fang, Z., Cui, L., Chen, S.-Y., Wang, J., Tan, Y., Wu, M., Chen, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26410-9 · Cited by 149 · cited 3×
“Trajectory inference reconstructs the emergence of major HLO lineages and injury-specific terminal states. have been studied so far by oleic acid (OA) treatment (Ouchi et al , 2019) and genetic manipulation (Guan et al , 2021).”
BackgroundSingle-cell atlas of human liver development reveals pathways directing hepatic cell fates
Wesley, B. T., Ross, A. D. B., Muraro, D., Miao, Z., Saxton, S., Tomaz, R. A., Morell, C. M., Ridley, K., Zacharis, E. D., Petrus-Reurer, S., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00989-7 · Cited by 146
Bipotent transitional liver progenitor cells contribute to liver regeneration
Pu, W., Zhu, H., Zhang, M., Pikiolek, M., Ercan, C., Li, J., Huang, X., Han, X., Zhang, Z., Lv, Z., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01335-9 · Cited by 138
Human in vitro models of nonalcoholic fatty liver disease
Müller, F. A., & Sturla, S. J. (2019) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2019.03.001 · Cited by 118 · cited 2×
“The free fatty acids (FFAs) oleic acid (OA) and palmitic acid (PA) accumulate in MASLD and thus are widely used to model MASLD in vitro (Mu¨ller & Sturla, 2019; Ramli et al , 2020).”
Generation of multi-cellular human liver organoids from pluripotent stem cells
(2020) · Methods in Cell Biology · doi:10.1016/bs.mcb.2020.03.009 · Cited by 55 · cited 3×
“For day 21 ULA HLO single-cell RNA sequencing, HLOs underwent a passage step at day 16 and remained in HCM medium with 10% Matrigel on ultra-low attachment plates as previously described (Thompson & Takebe, 2020).”
BackgroundMethod
Cited by
Multi-zonal liver organoids from human pluripotent stem cells
Reza, H. A., Santangelo, C., Iwasawa, K., Reza, A. A., Sekiya, S., Glaser, K., Bondoc, A., Merola, J., & Takebe, T. (2025) · Nature · doi:10.1038/s41586-025-08850-1 · Cited by 71
Constructing biomimetic microenvironments for liver regeneration
(2025) · doi:10.1186/s12951-025-03729-9 · Cited by 11
TNC‑targeted CAR‑macrophage therapy alleviates liver fibrosis in mice
Chen, K., Lin, Z., Chen, L., Zhou, Y., Zhang, W., Wan, H., Huo, Y., Fu, Q., Gao, Z., Cheng, H., et al. (2025) · Military Medical Research · doi:10.1186/s40779-025-00667-3 · Cited by 11
Yang, S., Hao, J., Ooka, M., & Xia, M. (2026) · Scientific Reports · doi:10.1038/s41598-025-32539-0 · Cited by 5
“…a comprehensive view of cellular differentiation pattern, more precise methods such as single-cell technologies (transcriptomics or proteomics) 38,39 and spatiotemporal single-cell tracking 40,41 would further elucidate the detailed cellular composition and 3D organization during iHLO…”
Metadata
- Authors
- Hess, A., Gentile, S. D., Ben Saad, A., Rahman, R., Habboub, T., Pratt, D. S., & Mullen, A. C.
- Venue
- The EMBO Journal
- Published
- 2023-11-14
- Volume
- 42
- Issue
- 24
- Pages
- e113898-e113898
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W4388672123
- Cited by
- 52
- References
- 50
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.